Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma

Table 2

Comparison of TIC types of before and mid-CCRT.

		Type 1	Type 2	Type 3	Type 4	value
Tumor	Baseline	19 (33.9%)	25 (44.6%)	4 (7.1%)	8 (14.3%)	<0.001
	Mid-CCRT	4 (7.1%)	15 (26.8%)	25 (44.6%)	12 (21.4%)
Control	Baseline	3 (5.4%)	7 (12.5%)	14 (25.0%)	32 (57.1%)	0.383
	Mid-CCRT	3 (5.4%)	5 (8.9%)	12 (21.4%)	36 (64.3%)